Literature DB >> 10071716

Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression.

B S Meyers1, G S Alexopoulos, T Kakuma, F Tirumalasetti, M Gabriele, S Alpert, C Bowden, H Y Meltzer.   

Abstract

BACKGROUND: Decreased dopamine beta-hydroxylase (DBH) activity has been reported in unipolar psychotic depression. DBH comparisons between elderly delusional and nondelusional depressives and controls and determination of whether pretreatment group differences persist have not been reported. Our objective was to compare DBH activity in elderly delusional major depressives with that of nondelusional depressives and normal control subjects before and after hospital treatment.
METHODS: Enzyme activity was assessed after hospital admission. A subsample had predischarge assessments. Treatment was not controlled but accounted for in analyses. Electroconvulsive therapy subjects were medication-free for posttreatment assays.
RESULTS: Baseline and predischarge DBH assays were lower in subjects with delusional depression than in either comparison group. Despite high intraindividual correlation, treatment was associated with significant increases in activity in the clinical groups.
CONCLUSIONS: Patients with late-life delusional depression have lower DBH activity before and after hospital treatment than age-matched nondelusional patients or normal controls.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071716     DOI: 10.1016/s0006-3223(98)00085-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

Review 1.  Psychotic major depression: a benefit-risk assessment of treatment options.

Authors:  Audrey R Tyrka; Lawrence H Price; Marcelo F Mello; Andrea F Mello; Linda L Carpenter
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

3.  Beyond heritability: neurotransmitter genes differentially modulate visuospatial attention and working memory.

Authors:  Raja Parasuraman; Pamela M Greenwood; Reshma Kumar; John Fossella
Journal:  Psychol Sci       Date:  2005-03

4.  Measuring psychotic depression.

Authors:  S D Østergaard; B S Meyers; A J Flint; B H Mulsant; E M Whyte; C M Ulbricht; P Bech; A J Rothschild
Journal:  Acta Psychiatr Scand       Date:  2013-06-25       Impact factor: 6.392

5.  Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia.

Authors:  Joseph F Cubells; Xiangqing Sun; Wenbiao Li; Robert W Bonsall; John A McGrath; Dimitri Avramopoulos; Virginia K Lasseter; Paula S Wolyniec; Yi-Lang Tang; Kristina Mercer; Ann E Pulver; Robert C Elston
Journal:  Hum Genet       Date:  2011-04-21       Impact factor: 4.132

Review 6.  Evaluation of newer treatment interventions for psychotic depression.

Authors:  B L O'Neal; C L Smith; M Trivedi
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

7.  Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Authors:  Rasmon Kalayasiri; Viroj Verachai; Joel Gelernter; Apiwat Mutirangura; Robert T Malison
Journal:  Addiction       Date:  2014-03-17       Impact factor: 6.526

Review 8.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

9.  A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.

Authors:  C Hess; A Reif; A Strobel; A Boreatti-Hümmer; M Heine; K-P Lesch; C P Jacob
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

10.  Regulation of rat dopamine beta-hydroxylase gene transcription by early growth response gene 1 (Egr1).

Authors:  Shu-Yuan Cheng; Lidia I Serova; Dina Glazkova; Esther L Sabban
Journal:  Brain Res       Date:  2007-12-05       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.